ALFA Filings
Every announcement, straight from the exchange
Every Samrat Pharmachem other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Samrat Pharmachem Ltd filed its quarterly shareholding pattern as mandated by SEBI regulations. This is a routine compliance disclosure detailing the company's ownership structure.
Samrat Pharmachem Limited appointed M/s Divyesh J Shah & Associates as Statutory Auditors following the expiry of the previous auditor's tenure at the 34th Annual General Meeting.
Samrat Pharmachem appointed Divyesh J Shah & Associates as Statutory Auditors for five years. The term spans from the 34th to 39th Annual General Meeting.
Samrat Pharmachem Limited submitted its Annual Secretarial Compliance Report for FY 2025-26. The report by A.A. Mulla & Associates confirms general regulatory adherence with minor historical filing delays.
Samrat Pharmachem Limited submitted a compliance certificate under Regulation 74(5) for the quarter ended March 31, 2026. The Registrar and Share Transfer Agent, MUFG Intime India, confirmed that securities received for dematerialisation were processed and listed on the stock exchange within prescribed timelines.